Prosecution Insights
Last updated: August 17, 2026

Wisconsin Alumni Research Foundation

85 pending office actions • 49 art units • 79 examiners • 0 of 85 (0%) have an AI response strategy ready • 117 patents granted in the last 365 days

Portfolio Summary

85
Total Pending OAs
54
Non-Final OAs
27
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 34 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

18
Overdue
2
Due this week
7
Due this month
4
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 34 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (18)Due ≤ 7 days (2)Due ≤ 30 days (7)Due ≤ 60 days (4)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

37
Hard (44%)
38
Medium (45%)
8
Easy (9%)
2
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only1 (1%)
§101 + other3 (4%)
§103 only31 (36%)
§102 only2 (2%)
§112 only6 (7%)
Double-patenting only2 (2%)
Double-patenting + other5 (6%)
Multi-statute (no §101)33 (39%)
No statute on record2 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

58
Life Sciences
68% of docket
3
Information Tech
4% of docket
1
Communications
1% of docket
5
Semiconductors
6% of docket
11
Mechanical / Eng
13% of docket
7
Business / Other
8% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

850 h
Manual time on pending OAs
170 h
Time saved (low, 20%)
298 h
Time saved (mid, 35%)
7.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAK, YONG D 2 74.6% +14.3%
GROOMS, TIFFANY NICOLE 2 58.8% +46.8%
PARENT, ALEXANDER RENE 2 55.3% +16.7%
CANELLA, KAREN A 2 62.1% +32.9%
STAVROU, CONSTANTINA E 2 44.2% +36.3%
BELYAVSKYI, MICHAIL A 2 64.1% +27.7%
LUONG, DUY HAN 1 94.7% +8.3%
SCHERBEL, TODD J 1 76.2% +52.3%
KOWALKOWSKI, FIONA MARGARET 1 100.0% +0.0%
SINCLAIR, DAVID M 1 68.4% +19.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18989456 Photonic Static Random Access Memory LUONG, DUY HAN

Hard Cases (37)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18322861 LIGHT-EMITTERS WITH GROUP III-NITRIDE-BASED QUANTUM WELL ACTIVE REGIONS HAVING GAN INTERLAYERS KIM, JAY C 117d overdue
17833178 Ultrasound Probe Hand Shield ROZANSKI, MICHAEL T 91d overdue
18236638 Heterogeneous Processor With High-Speed Decision Tree Scheduler CAO, DIEM K 43d overdue
18231997 Clip on Torque Device for Endovascular Procedures WITTLIFF, KATERINA ANNA 28d overdue
18122661 METHOD OF MANUFACTURING MICELLES FOR DRUG DELIVERY HELM, CARALYNNE E 28d overdue
18599008 BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION CHEONG, CHEOM-GIL 9d overdue
17904706 Bispecific GD2 and B7H3 Binding Molecules and Methods of Use BELYAVSKYI, MICHAIL A 8d overdue
18304694 METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION PYLA, EVELYN Y 14d

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18658840 YEAST STRAINS WITH SELECTED OR ALTERED MITOTYPES AND METHODS OF MAKING AND USING THE SAME GROOMS, TIFFANY NICOLE 51d overdue
17904706 Bispecific GD2 and B7H3 Binding Molecules and Methods of Use BELYAVSKYI, MICHAIL A 8d overdue
18057026 Methods for Printing Functional Human Neural Tissue STAVROU, CONSTANTINA E 5d
16547907 EXPANSION OF HPSC-DERIVED GRANULOCYTIC AND LYMPHOID PROGENITORS WITH UM171 BELYAVSKYI, MICHAIL A 7d
18972024 TISSUE MANIPULATION AND CUTTING DEVICE AND RELATED METHODS SCHERBEL, TODD J
18910720 AMPLIFICATION OF INTERFACIAL CAPACITANCE IN IONIC LIQUID ELECTROLYTES SINCLAIR, DAVID M
18891498 MICROORGANISMS AND METHODS FOR PRODUCING CIS,CIS-MUCONIC ACID PAK, YONG D
18737647 RECOMBINANT MICROORGANISMS THAT CATABOLIZE LIGNIN AROMATICS AND METHODS OF USING SAME PAK, YONG D

Top Art Units

Art UnitApps
1653 5
1637 4
1645 3
1638 3
1644 3
1631 3
3792 2
1662 2
2488 2
1652 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18989456 Photonic Static Random Access Memory LUONG, DUY HAN 2825 §112 Non-Final OA Pending Dec 20, 2024
18972024 TISSUE MANIPULATION AND CUTTING DEVICE AND RELATED METHODS SCHERBEL, TODD J 3771 §102§103§112 Non-Final OA Pending Dec 06, 2024
18955228 Localizing Ion-Channel Activation Using Nullifying Waveforms KOWALKOWSKI, FIONA MARGARET 3792 §102§103§112 Non-Final OA Pending Nov 21, 2024
18910720 AMPLIFICATION OF INTERFACIAL CAPACITANCE IN IONIC LIQUID ELECTROLYTES SINCLAIR, DAVID M 2847 §103 Non-Final OA Pending Oct 09, 2024
18906694 DEREGULATED DHS AND TYRA ENZYMES OF GRASSES ENABLE EFFICIENT PRODUCTION OF BOTH TYROSINE AND PHENYLALANINE TAMUKONG, YVETTE BIH 1662 DP Non-Final OA Pending Oct 04, 2024
18891498 MICROORGANISMS AND METHODS FOR PRODUCING CIS,CIS-MUCONIC ACID PAK, YONG D §102§103§112 Non-Final OA Pending Sep 20, 2024
18819158 Generating Vasculogenic Cell Populations SCHUBERG, LAURA J §103§112DP Non-Final OA Pending Aug 29, 2024
18755293 SYSTEMS, METHODS, AND MEDIA FOR CONCURRENT DEPTH AND MOTION ESTIMATION USING INDIRECT TIME OF FLIGHT IMAGING XU, XIAOLAN 2488 §103 Non-Final OA 41d Pending Jun 26, 2024
18743376 MICROORGANISMS AND METHODS FOR PRODUCING REUTERIN SAIDHA, TEKCHAND 1652 §112Other Non-Final OA Pending Jun 14, 2024
18737647 RECOMBINANT MICROORGANISMS THAT CATABOLIZE LIGNIN AROMATICS AND METHODS OF USING SAME PAK, YONG D 1652 §103§112 Non-Final OA Pending Jun 07, 2024
18714481 DEVELOPMENT OF FOOD-GRADE FUNGAL FERMENTATES WITH ANTIMICROBIAL ACTIVITY AND THE USE THEREOF AFREMOVA, VERA 1653 §102§103 Non-Final OA Pending May 29, 2024
18660385 Piezoelectric Stents with Self-Powered Anti-Restenosis Properties MANNAN, MIKAIL A §103 Non-Final OA Pending May 10, 2024
18658840 YEAST STRAINS WITH SELECTED OR ALTERED MITOTYPES AND METHODS OF MAKING AND USING THE SAME GROOMS, TIFFANY NICOLE 1637 §103 Final Rejection 51d overdue Pending May 08, 2024
18708496 MUTANT ACE2 PROTEINS AND METHODS OF USING SAME EIX, EMILY FAY 1653 §103 Non-Final OA Pending May 08, 2024
18632978 METHOD TO INHIBIT NEUTROPHIL RECRUITMENT TO DAMAGED TISSUE USING MYELOID-DERIVED GROWTH FACTOR AUDET, MAURY A 1654 §112 Non-Final OA 147d overdue Pending Apr 11, 2024
18629296 VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME SHOMER, ISAAC 1612 §103§112 Non-Final OA Pending Apr 08, 2024
18623989 GENERALIZED EVENT CAMERA DHILLON, PUNEET S 2488 §103 Non-Final OA 86d overdue Pending Apr 01, 2024
18613041 REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION TAKENAKA, RISA 1653 §102§103§112 Non-Final OA Pending Mar 21, 2024
18612463 HIGH THROUGHPUT NEWBORN SCREENING ASSAY FOR ANGELMAN AND PRADER-WILLI SYNDROMES BROWN, MINDY G §101§103§112 Non-Final OA Pending Mar 21, 2024
18599008 BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION CHEONG, CHEOM-GIL 1645 §101§102§103§112Other Non-Final OA 9d overdue Pending Mar 07, 2024
18596320 METHODS OF INDUCING CARDIAC CELL PROLIFERATION AND INDUCING HEART REGENERATION ALSOMAIRY, SARAH ABDOALATIF §102§103§112 Non-Final OA Pending Mar 05, 2024
18440260 EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS LARA, CAROLINE MONSERRAT 1633 §102§112DP Non-Final OA Pending Feb 13, 2024
18439978 METHODS OF FORMING SYNTACTIC FOAMS USING SELECTIVE LASER SINTERING SANDERS, JAMES M 1743 §103 Final Rejection Pending Feb 13, 2024
18435421 Acoustic Subwavelength Imaging System ARMSTRONG, JONATHAN D 3645 §102§103 Non-Final OA 26d Pending Feb 07, 2024
18434662 LIPOPEPTIDES, NANOPARTICLES AND METHODS OF USE KWON, JOHN SEUNGJAI §102§103 Non-Final OA Pending Feb 06, 2024
18426920 SYNTHESIS OF NOVEL CEREBLON E3 LIGASE LIGANDS, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM OTTON, ALICIA L 1699 §102 Non-Final OA Pending Jan 30, 2024
18424697 STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY WESTERBERG, NISSA M 1618 §103§112Other Non-Final OA 16d Pending Jan 26, 2024
18417305 SYNTHETIC YEAST CELLS AND METHODS OF MAKING AND USING THE SAME RYAN, DOUGLAS CHARLES 1635 §112 Final Rejection 127d overdue Pending Jan 19, 2024
18396865 ELECTROCHEMICAL LITHIUM EXTRACTION AND RECOVERY PARENT, ALEXANDER RENE 1795 §103 Final Rejection Pending Dec 27, 2023
18572146 ELECTROCHEMICAL REDUCTIVE COUPLING OF PHENOL DERIVATIVES HASKE, WOJCIECH 1794 §103 Final Rejection 23d overdue Pending Dec 19, 2023
18532418 METAL COMPOUND BASED CATALYSTS FOR ELECTROSYNTHESIS OF HYDROGEN PEROXIDE AND LINEAR PAIRED ELECTROCHEMICAL VALORIZATION OF BIOMASS-DERIVED FEEDSTOCKS MENDEZ, ZULMARIAM §103 Non-Final OA Pending Dec 07, 2023
18566460 High Temperature Reactor With Reduced Silo Height DAVIS, SHARON M 3646 §103§112 Non-Final OA Pending Dec 01, 2023
18565772 OXYGEN ION TRANSPORT MATERIALS AND RELATED DEVICES DAVIS, SHENG HAN 1732 §103 Non-Final OA Pending Nov 30, 2023
18508825 GENETICALLY ENCODED SYNTHETIC REACTION-DIFFUSION SYSTEM THAT CAN GENERATE PROGRAMMABLE OSCILLATIONS, PATTERNS, AND SPATIOTEMPORAL SIGNALING CIRCUITS IN MAMMALIAN CELLS ARMATO JR, DENNIS IGNATIUS 1651 §102§103 Non-Final OA Pending Nov 14, 2023
18373418 COMPOSITIONS AND METHODS FOR IMPROVING CARDIAC STRUCTURE AND/OR FUNCTION SZNAIDMAN, MARCOS L 1628 Other Non-Final OA Pending Sep 27, 2023
18471452 BIOMIMETIC CATALYSTS FOR DIVERSE INDUSTRIAL APPLICATIONS IN CHEMICAL REACTIONS LEAVITT, MORDECAI MIZANI 1742 §102§103 Non-Final OA Pending Sep 21, 2023
18471422 Compositions and Methods to Enhance Therapeutic Efficacy of Cancer Therapies CHHAY, BONIRATH 1645 §103§112 Non-Final OA Pending Sep 21, 2023
18236638 Heterogeneous Processor With High-Speed Decision Tree Scheduler CAO, DIEM K 2196 §103§112 Final Rejection 43d overdue Pending Aug 22, 2023
18451614 NONIONIC, REDOX-CLEAVABLE SURFACTANT FOR MASS SPECTROMETRY-BASED PROTEOMICS AND STRUCTURAL BIOLOGICAL APPLICATIONS XU, XIAOYUN 1797 §102 Non-Final OA Pending Aug 17, 2023
18231997 Clip on Torque Device for Endovascular Procedures WITTLIFF, KATERINA ANNA 3783 §102§103 Final Rejection 28d overdue Pending Aug 09, 2023
18446192 AMPHIPHILIC COMPLEXING AGENTS FOR IMPROVED MEMBRANE COMPATIBILITY AND STABILITY OF REDOX SPECIES ORDUNA, TAMARA 1776 §102§103 Final Rejection Pending Aug 08, 2023
18229901 Nuclear Fuel Assembly Retrofit for Increasing Reactor Power GARNER, LILY CRABTREE 3646 §102§103§112 Non-Final OA 84d Pending Aug 03, 2023
18261267 FREEZING AND JACKETING GAS-PHASE BIOMOLECULES WITH AMORPHOUS ICE FOR ELECTRON MICROSCOPY BOWERS, NATHAN ANDREW 1799 §103 Final Rejection 43d overdue Pending Jul 13, 2023
18351246 Macrophage Cell Therapy to Treat Orthopedic Injury WEHBE, ANNE MARIE SABRINA 1634 §112 Non-Final OA Pending Jul 12, 2023
18218325 METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION KIFLE, BRUCK 1624 §112DPOther Non-Final OA 61d Pending Jul 05, 2023
18345385 Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination CANELLA, KAREN A 1643 DP Non-Final OA Pending Jun 30, 2023
18256805 REGULATORY ELEMENTS FOR SCHWANN CELL-SPECIFIC GENE EXPRESSION GIBBS, TERRA C 1635 §102§103 Final Rejection 27d Pending Jun 09, 2023
18332380 GENERATION OF NEXT GENERATION RECOMBINANT AAV GENE THERAPY VECTORS THAT ADOPT 3D CONFORMATION VIVLEMORE, TRACY ANN 1638 §103Other Non-Final OA 9d Pending Jun 09, 2023
18332457 Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity STOICA, ELLY GERALD 1618 §103§112DP Non-Final OA Pending Jun 09, 2023
18255609 POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION SAOUD, CHRISTINE J 1645 §101§112 Non-Final OA Pending Jun 02, 2023
18201887 Use of Non-Invasive Sensory Systems to Titrate Cranial Nerve Stimulation to Enhance Brain Clearance Closed-Loop EDWARDS, PHILIP CHARLES 3792 §103§112 Final Rejection Pending May 25, 2023
18322861 LIGHT-EMITTERS WITH GROUP III-NITRIDE-BASED QUANTUM WELL ACTIVE REGIONS HAVING GAN INTERLAYERS KIM, JAY C 2815 §103§112 Final Rejection 117d overdue Pending May 24, 2023
18304694 METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION PYLA, EVELYN Y 1633 §102§103§112 Non-Final OA 14d Pending Apr 21, 2023
18250065 MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY PEEBLES, KATHERINE 1617 §103Other Final Rejection 45d overdue Pending Apr 21, 2023
18302636 COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS MELCHIOR, JAMES RYLAND 1644 §103§112 Non-Final OA 84d Pending Apr 18, 2023
18300531 Electric Motor Providing Bearing-Force Unloading KENERLY, TERRANCE L 2834 §102§103 Non-Final OA Pending Apr 14, 2023
18298468 System and Method for Monitoring Lesion Progression Over Multiple Medical Scans KOETH, MICHELLE M 2671 §103 Final Rejection 8d overdue Pending Apr 11, 2023
18295036 SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING TATGE, LEXUS MARC 1637 §103§112 Non-Final OA Pending Apr 03, 2023
18189056 COMBINATORIAL PLATFORM FOR HIGH-THROUGHPUT POLYNUCLEOTIDE-ENCODED CATALYST DISCOVERY GROSS, CHRISTOPHER M 1684 §103 Final Rejection Pending Mar 23, 2023
18122661 METHOD OF MANUFACTURING MICELLES FOR DRUG DELIVERY HELM, CARALYNNE E 1615 §103§112 Final Rejection 28d overdue Pending Mar 16, 2023
18182850 Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies CANELLA, KAREN A 1643 Other Non-Final OA Pending Mar 13, 2023
18178205 Surface Hydration with an Ion Beam LOGIE, MICHAEL J 2881 §102§103§112 Non-Final OA 54d Pending Mar 03, 2023
18004271 CONJUGATION OF PROTEINS TO POLYSACCHARIDES USING A PHOSPHATE BRIDGE LEE, HOI YAN NMN 1693 §103 Final Rejection 161d overdue Pending Jan 04, 2023
18058419 RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS GROOMS, TIFFANY NICOLE 1637 §103 Final Rejection Pending Nov 23, 2022
18057026 Methods for Printing Functional Human Neural Tissue STAVROU, CONSTANTINA E 1632 §103 Final Rejection 5d Pending Nov 18, 2022
17926113 MULTI-FUNCTIONAL GSH-RESPONSIVE SILICA NANOPARTICLES FOR DELIVERY OF BIOMOLECULES INTO PLANT CELLS BOYKIN, TERRESSA M 1662 §103Other Non-Final OA Pending Nov 17, 2022
17980883 METHODS OF GENOME EDITING INCLUDING CONTROLLED OPENING OF CHROMATIN ALLEN, SARAH ELIZABETH 1637 §103 Final Rejection Pending Nov 04, 2022
17973020 Simplified Compositions and Methods for Generating Neural Stem Cells from Human Pluripotent Stem Cells DUTT, ADITI 1675 §112DP Non-Final OA Pending Oct 25, 2022
17996917 LIPID-PEPTIDE FUSION INHIBITORS AS SARS-COV-2 ANTIVIRALS COFFA, SERGIO 1658 §102§103Other Non-Final OA 21d Pending Oct 21, 2022
17946481 SYSTEM AND METHOD FOR IMAGING ORGANS WITH MULTIPLE BLOOD SUPPLIES POPESCU, GABRIEL VICTOR 3797 §103 Non-Final OA Pending Sep 16, 2022
17904706 Bispecific GD2 and B7H3 Binding Molecules and Methods of Use BELYAVSKYI, MICHAIL A 1644 §102§103 Non-Final OA 8d overdue Pending Aug 19, 2022
17811640 Tissue Load Sensor with Reduced Calibration Requirements WARSI, YASMEEN S 3791 §101 Non-Final OA Pending Jul 11, 2022
17853441 MEDIATED HYDROGEN ANODE FOR USE IN REDUCTIVE ELECTROSYNTHESIS PARENT, ALEXANDER RENE 1795 §103§112 Non-Final OA Pending Jun 29, 2022
17833178 Ultrasound Probe Hand Shield ROZANSKI, MICHAEL T 3797 §102§103§112 Non-Final OA 91d overdue Pending Jun 06, 2022
17545416 METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES STAVROU, CONSTANTINA E 1632 §103 Non-Final OA Pending Dec 08, 2021
17609064 WASHED PLATELET EXTRACT NGUYEN, NGHI V 1653 §103 Final Rejection Pending Nov 05, 2021
17495597 MULTICELL CONJUGATES FOR ACTIVATING ANTIGEN-SPECIFIC T CELL RESPONSES ZHU, JIANJIAN 1631 §103 Final Rejection 35d overdue Pending Oct 06, 2021
17407606 NONVIRAL GENERATION OF GENOME EDITED CHIMERIC ANTIGEN RECEPTOR T CELLS SPENCER, ANDREA LYNNE MORRIS 1631 §103 Final Rejection Pending Aug 20, 2021
17427180 DEVICES AND METHODS FOR MEASURING BRAIN STATE COOPER, JONATHAN EPHRAIM 3791 §103 Final Rejection 29d Pending Jul 30, 2021
17345773 Methods for Cardiac Fibroblast Differentiation of Human Pluripotent Stem Cells WILSON, MICHAEL C 1638 §103 Final Rejection 34d Pending Jun 11, 2021
17343647 COMPOSITIONS AND METHODS FOR PRECISE PATTERNING OF POSTERIOR NEUROECTODERM FROM HUMAN PLURIPOTENT STEM CELLS WILLIAMS, EMMALEE RAE 1653 §103 Final Rejection Pending Jun 09, 2021
17323715 GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS ROGERS, ERIC JASON 1638 §102§103§112 Non-Final OA 53d Pending May 18, 2021
17117062 IN VITRO EXPANSION OF DOPAMINERGIC SUBTYPE NEURONAL PROGENITORS DERIVED FROM PLURIPOTENT STEM CELLS MIANO, JOSEPH PAUL 1631 §103 Non-Final OA Pending Dec 09, 2020
16876353 EFFICIENT, SCALABLE PRODUCTION OF HUMAN RETINAL PROGENITORS IN VITRO WANG, CHANG YU 1675 §112 Non-Final OA 4d overdue Pending May 18, 2020
16547907 EXPANSION OF HPSC-DERIVED GRANULOCYTIC AND LYMPHOID PROGENITORS WITH UM171 BELYAVSKYI, MICHAIL A 1644 §103Other Final Rejection 7d Pending Aug 22, 2019

Managing Wisconsin Alumni Research Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month